» Articles » PMID: 37460554

Engineering Tumoral Vascular Leakiness with Gold Nanoparticles

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Jul 17
PMID 37460554
Authors
Affiliations
Soon will be listed here.
Abstract

Delivering cancer therapeutics to tumors necessitates their escape from the surrounding blood vessels. Tumor vasculatures are not always sufficiently leaky. Herein, we engineer therapeutically competent leakage of therapeutics from tumor vasculature with gold nanoparticles capable of inducing endothelial leakiness (NanoEL). These NanoEL gold nanoparticles activated the loss of endothelial adherens junctions without any perceivable toxicity to the endothelial cells. Microscopically, through real time live animal intravital imaging, we show that NanoEL particles induced leakiness in the tumor vessels walls and improved infiltration into the interstitial space within the tumor. In both primary tumor and secondary micrometastases animal models, we show that pretreatment of tumor vasculature with NanoEL particles before therapeutics administration could completely regress the cancer. Engineering tumoral vasculature leakiness represents a new paradigm in our approach towards increasing tumoral accessibility of anti-cancer therapeutics instead of further increasing their anti-cancer lethality.

Citing Articles

Size-dependent interactions between calciprotein particles and vascular endothelium.

Zhang Z, Wang X, Huang C, Wang M, Cui W, Hao L Mater Today Bio. 2025; 31:101599.

PMID: 40070870 PMC: 11894339. DOI: 10.1016/j.mtbio.2025.101599.


Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.


Simultaneous Down-Regulation of Intracellular MicroRNA-21 and hTERT mRNA Using AS1411-Functionallized Gold Nanoprobes to Achieve Targeted Anti-Tumor Therapy.

Ji Q, Yang Q, Ou M, Hong M Nanomaterials (Basel). 2024; 14(23).

PMID: 39683343 PMC: 11643209. DOI: 10.3390/nano14231956.


Lateral nanoarchitectonics from nano to life: ongoing challenges in interfacial chemical science.

Song J, Jancik-Prochazkova A, Kawakami K, Ariga K Chem Sci. 2024; 15(45):18715-18750.

PMID: 39568623 PMC: 11575615. DOI: 10.1039/d4sc05575f.


Nanoparticle Delivery to Tumours: From EPR and ATR Mechanisms to Clinical Impact.

Dasgupta A, Sofias A, Kiessling F, Lammers T Nat Rev Bioeng. 2024; 2(9):714-716.

PMID: 39376248 PMC: 7616668. DOI: 10.1038/s44222-024-00203-3.


References
1.
Setyawati M, Tay C, Bay B, Leong D . Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin. ACS Nano. 2017; 11(5):5020-5030. DOI: 10.1021/acsnano.7b01744. View

2.
Adam A, Sharenko A, Pumiglia K, Vincent P . Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem. 2010; 285(10):7045-55. PMC: 2844154. DOI: 10.1074/jbc.M109.079277. View

3.
Setyawati M, Mochalin V, Leong D . Tuning Endothelial Permeability with Functionalized Nanodiamonds. ACS Nano. 2015; 10(1):1170-81. DOI: 10.1021/acsnano.5b06487. View

4.
Pacurari M, Qian Y, Fu W, Schwegler-Berry D, Ding M, Castranova V . Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells. J Toxicol Environ Health A. 2011; 75(2):112-28. PMC: 3230883. DOI: 10.1080/15287394.2011.615110. View

5.
Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A . Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999; 285(5429):895-8. DOI: 10.1126/science.285.5429.895. View